
    
      This is a single center, not-randomized open study. The study medication consists of
      L-citrulline and metformin administered orally; 5g citrulline and 500mg metformin tablets
      will be given 3 times daily.

      Half of the patients will be treated with metformin during the first 6 weeks of the study.
      The other patients will receive initially L-citrulline for 6 weeks, before all patients will
      be treated with the combination therapy (metformin and L-citrulline) for another 6 week
      period.

      The study lasts 12 weeks and includes the screening visit and 3 further visits at baseline,
      week 6 and week 12.
    
  